Alzheimer’s gene neutralised in human brain cells for first time
Development comes after scientists switch away from testing on mouse cells
Scientists have claimed a major breakthrough in the battle against Alzheimer’s by neutralising a key gene that significantly increases the risk of developing the disease.
A team at Gladstone Institutes, in California, “successfully identified the protein associated with the high-risk apoE4 gene and then managed to prevent it damaging human neuron cells”, reports The Daily Telegraph.
The research, published in the journal Nature, reveals how the apoE4 gene confers its risk for Alzheimer’s in human brain cells.
Subscribe to The Week
Escape your echo chamber. Get the facts behind the news, plus analysis from multiple perspectives.
Sign up for The Week's Free Newsletters
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
“What’s more, they were able to erase the damage caused by apoE4 by changing it, with a small molecule, into a harmless apoE3-like version”, says news website ScienceDaily.
Having one copy of the apoE4 gene “more than doubles a person’s likelihood of developing Alzheimer’s disease, whereas having two copies increases the risk 12-fold”, says the Telegraph.
Previous studies “have indicated that roughly one in four people carry the gene”, the newspaper reports.
The latest breakthrough adds to hopes of finding a drug treatment that could halt the onset of the disease. The researchers have urged caution, however, pointing out that the neutralising process has only been tried in lab conditions as yet.
The development came after the California team decided to shun traditional testing methods.
Most Alzheimer’s research and drug development “are done in mouse models of the disease”, says ScienceDaily.
“Drug development for Alzheimer's disease has been largely a disappointment over the past ten years,” says lead study author Yadong Huang. “Many drugs work beautifully in a mouse model, but so far they’ve all failed in clinical trials. One concern within the field has been how poorly these mouse models really mimic human disease.”
Following a succession of clinical trial failures, Huang and his colleagues decided to use human cells to model the disease and test new drugs, leading to their discovery.
Sign up for Today's Best Articles in your inbox
A free daily email with the biggest news stories of the day – and the best features from TheWeek.com
-
5 humorously efficient cartoons about Trump's DOGE
Artists take on Trump's minions, wasteful spending, and more
By The Week US Published
-
Rupert Murdoch's succession problem
Talking Point A court ruling has thrown the future leadership of News Corp and Fox wide open. What next?
By The Week UK Published
-
Diversity training: a victim of the 'war on woke'
Talking Point More and more US companies have phased out corporate DEI initiatives, and the incoming Trump administration is likely to fuel the cultural shift
By The Week UK Published
-
Why Assad fell so fast
The Explainer The newly liberated Syria is in an incredibly precarious position, but its too soon to succumb to defeatist gloom
By The Week UK Published
-
Romania's election rerun
The Explainer Shock result of presidential election has been annulled following allegations of Russian interference
By Sorcha Bradley, The Week UK Published
-
Russia's shadow war in Europe
Talking Point Steering clear of open conflict, Moscow is slowly ratcheting up the pressure on Nato rivals to see what it can get away with.
By The Week UK Published
-
Cutting cables: the war being waged under the sea
In the Spotlight Two undersea cables were cut in the Baltic sea, sparking concern for the global network
By The Week UK Published
-
The nuclear threat: is Vladimir Putin bluffing?
Talking Point Kremlin's newest ballistic missile has some worried for Nato nations
By The Week UK Published
-
Russia vows retaliation for Ukrainian missile strikes
Speed Read Ukraine's forces have been using U.S.-supplied, long-range ATCMS missiles to hit Russia
By Arion McNicoll, The Week UK Published
-
Has the Taliban banned women from speaking?
Today's Big Question 'Rambling' message about 'bizarre' restriction joins series of recent decrees that amount to silencing of Afghanistan's women
By Harriet Marsden, The Week UK Published
-
Cuba's energy crisis
The Explainer Already beset by a host of issues, the island nation is struggling with nationwide blackouts
By Rebekah Evans, The Week UK Published